Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 27-Mar-24 11:55 AM View:  | Braunstein Scott Chairman and CEO Director | Marinus Pharmaceuticals, Inc. (MRNS) | 27-Mar-24 | Option Exercise | 50,000 | $4.28 | $214,000.00 | 22% 223.51K to 273.51K | |
| 22-Feb-24 4:05 PM View: | Manning Martha E SVP, GEN. COUNSEL & CORP. SEC. | Marinus Pharmaceuticals, Inc. (MRNS) | 20-Feb-24 | Market Sale (Planned) | 1,894 | $9.57 | $18,125.60 | (3%) 54.86K to 52.97K | (18%) |
| 22-Feb-24 4:05 PM View: | Shafer Christina Chief Commercial Officer | Marinus Pharmaceuticals, Inc. (MRNS) | 20-Feb-24 | Market Sale (Planned) | 2,153 | $9.56 | $20,582.70 | (3%) 62.46K to 60.31K | (18%) |
| 21-Feb-24 4:05 PM View: | Pfanstiel Steven CFO AND COO | Marinus Pharmaceuticals, Inc. (MRNS) | 16-Feb-24 | Market Sale (Planned) | 3,092 | $9.97 | $30,827.20 | (4%) 74.79K to 71.7K | (13%) |
| 21-Feb-24 4:05 PM View: | Braunstein Scott Chairman and CEO Director | Marinus Pharmaceuticals, Inc. (MRNS) | 16-Feb-24 | Market Sale (Planned) | 11,850 | $9.94 | $117,789.00 | (5%) 235.36K to 223.51K | (14%) |
| 21-Feb-24 4:06 PM View: | Hulihan Joseph Chief Medical Officer | Marinus Pharmaceuticals, Inc. (MRNS) | 16-Feb-24 | Market Sale (Planned) | 2,814 | $9.98 | $28,083.70 | (4%) 69.45K to 66.64K | (13%) |
| 19-Jan-24 4:23 PM View: | Nochur Sara Director | Marinus Pharmaceuticals, Inc. (MRNS) | 18-Jan-24 | Grant | 4,600 | -- | -- | 72% 6.35K to 10.95K | |
| 19-Jan-24 4:18 PM View: | Braunstein Scott Chairman and CEO Director | Marinus Pharmaceuticals, Inc. (MRNS) | 18-Jan-24 | Grant | 74,600 | -- | -- | 46% 160.76K to 235.36K | |
| 19-Jan-24 4:26 PM View: | Ezickson Elan Director | Marinus Pharmaceuticals, Inc. (MRNS) | 18-Jan-24 | Grant | 4,600 | -- | -- | 82% 5.6K to 10.2K | |
| 19-Jan-24 4:25 PM View: | Fischer Seth H.Z. Director | Marinus Pharmaceuticals, Inc. (MRNS) | 18-Jan-24 | Grant | 4,600 | -- | -- | 76% 6.03K to 10.63K | |
| 19-Jan-24 4:23 PM View: | Austin Charles Director | Marinus Pharmaceuticals, Inc. (MRNS) | 18-Jan-24 | Grant | 4,600 | -- | -- | 87% 5.28K to 9.88K | |
| 19-Jan-24 4:28 PM View: | Noonberg Sarah B. Director | Marinus Pharmaceuticals, Inc. (MRNS) | 18-Jan-24 | Grant | 4,600 | -- | -- | 64% 7.2K to 11.8K | |
| 19-Jan-24 4:21 PM View: | Manning Martha E SVP, GEN. COUNSEL & CORP. SEC. | Marinus Pharmaceuticals, Inc. (MRNS) | 18-Jan-24 | Grant | 21,835 | -- | -- | 66% 33.02K to 54.86K | |
| 19-Jan-24 4:22 PM View: | Mayleben Timothy M Director | Marinus Pharmaceuticals, Inc. (MRNS) | 18-Jan-24 | Grant | 4,600 | -- | -- | 26% 17.48K to 22.07K | |
| 19-Jan-24 4:20 PM View: | Hulihan Joseph Chief Medical Officer | Marinus Pharmaceuticals, Inc. (MRNS) | 18-Jan-24 | Grant | 21,835 | -- | -- | 46% 47.61K to 69.45K | |
| 19-Jan-24 4:21 PM View: | Shafer Christina Chief Commercial Officer | Marinus Pharmaceuticals, Inc. (MRNS) | 18-Jan-24 | Grant | 21,835 | -- | -- | 54% 40.63K to 62.46K | |
| 19-Jan-24 4:27 PM View: | Silverstein Christine Berni Director | Marinus Pharmaceuticals, Inc. (MRNS) | 18-Jan-24 | Grant | 4,600 | -- | -- | 64% 7.2K to 11.8K | |
| 19-Jan-24 4:27 PM View: | Johnson Marvin Director | Marinus Pharmaceuticals, Inc. (MRNS) | 18-Jan-24 | Grant | 4,600 | -- | -- | 64% 7.2K to 11.8K | |
| 19-Jan-24 4:19 PM View: | Pfanstiel Steven CFO AND COO | Marinus Pharmaceuticals, Inc. (MRNS) | 18-Jan-24 | Grant | 25,465 | -- | -- | 52% 49.32K to 74.79K | |
| 08-Aug-23 9:05 PM View: | Manning Martha E SVP, GEN. COUNSEL & CORP. SEC. | Marinus Pharmaceuticals, Inc. (MRNS) | 08-Aug-23 | Sale (Planned) | 11 | $8.93 | $98.23 | (< 1%) 33.04K to 33.02K | |
| 08-Aug-23 9:05 PM View: | Hulihan Joseph Chief Medical Officer | Marinus Pharmaceuticals, Inc. (MRNS) | 08-Aug-23 | Sale (Planned) | 13 | $8.93 | $116.09 | (< 1%) 47.63K to 47.61K | |
| 08-Aug-23 9:05 PM View: | Shafer Christina Chief Commercial Officer | Marinus Pharmaceuticals, Inc. (MRNS) | 08-Aug-23 | Sale (Planned) | 11 | $8.93 | $98.23 | (< 1%) 40.64K to 40.63K | |
| 08-Aug-23 9:05 PM View: | Pfanstiel Steven CFO AND COO | Marinus Pharmaceuticals, Inc. (MRNS) | 08-Aug-23 | Sale (Planned) | 14 | $8.93 | $125.02 | (< 1%) 49.34K to 49.32K | |
| 08-Aug-23 9:05 PM View: | Braunstein Scott Chairman and CEO Director | Marinus Pharmaceuticals, Inc. (MRNS) | 08-Aug-23 | Sale (Planned) | 30 | $8.94 | $268.20 | (< 1%) 160.79K to 160.76K | |
| 08-Aug-23 9:05 PM View: | Pfanstiel Steven CFO AND COO | Marinus Pharmaceuticals, Inc. (MRNS) | 07-Aug-23 | Sale (Planned) | 2,790 | $9.54 | $26,616.60 | (5%) 52.13K to 49.34K | |
| 08-Aug-23 9:05 PM View: | Braunstein Scott Chairman and CEO Director | Marinus Pharmaceuticals, Inc. (MRNS) | 07-Aug-23 | Market Sale (Planned) | 6,413 | $9.55 | $61,244.20 | (4%) 167.21K to 160.79K | (18%) |
| 08-Aug-23 9:05 PM View: | Manning Martha E SVP, GEN. COUNSEL & CORP. SEC. | Marinus Pharmaceuticals, Inc. (MRNS) | 07-Aug-23 | Sale (Planned) | 2,169 | $9.54 | $20,692.30 | (6%) 35.2K to 33.04K | |
| 08-Aug-23 9:05 PM View: | Hulihan Joseph Chief Medical Officer | Marinus Pharmaceuticals, Inc. (MRNS) | 07-Aug-23 | Market Sale (Planned) | 2,889 | $9.55 | $27,590.00 | (6%) 50.52K to 47.63K | (18%) |
| 08-Aug-23 9:05 PM View: | Shafer Christina Chief Commercial Officer | Marinus Pharmaceuticals, Inc. (MRNS) | 07-Aug-23 | Sale (Planned) | 2,385 | $9.52 | $22,705.20 | (6%) 43.02K to 40.64K | |
| 17-May-23 9:08 PM View: | Noonberg Sarah B. Director | Marinus Pharmaceuticals, Inc. (MRNS) | 16-May-23 | Grant | 7,200 | -- | -- | 100% 0 to 7.2K | |
| 19-Apr-23 4:03 PM View: | Johnson Marvin Director | Marinus Pharmaceuticals, Inc. (MRNS) | 17-Apr-23 | Grant | 7,200 | -- | -- | 100% 0 to 7.2K | |
| 08-Feb-23 4:36 PM View: | Ezickson Elan Director | Marinus Pharmaceuticals, Inc. (MRNS) | 06-Feb-23 | Sale (Planned) | 750 | $6.56 | $4,920.00 | (12%) 6.35K to 5.6K | |
| 08-Feb-23 4:37 PM View: | Fischer Seth H.Z. Director | Marinus Pharmaceuticals, Inc. (MRNS) | 06-Feb-23 | Sale (Planned) | 1,018 | $6.54 | $6,657.72 | (14%) 7.04K to 6.03K | |
| 08-Feb-23 4:36 PM View: | Austin Charles Director | Marinus Pharmaceuticals, Inc. (MRNS) | 06-Feb-23 | Sale (Planned) | 1,073 | $6.49 | $6,963.77 | (17%) 6.35K to 5.28K | |
| 30-Jan-23 4:22 PM View: | Mayleben Timothy M Director | Marinus Pharmaceuticals, Inc. (MRNS) | 26-Jan-23 | Grant | 3,600 | -- | -- | 26% 13.88K to 17.48K | |
| 30-Jan-23 4:45 PM View: | Braunstein Scott Chairman and CEO Director | Marinus Pharmaceuticals, Inc. (MRNS) | 26-Jan-23 | Grant | 80,000 | -- | -- | 92% 87.2K to 167.21K | |
| 30-Jan-23 4:30 PM View: | Shafer Christina Chief Commercial Officer | Marinus Pharmaceuticals, Inc. (MRNS) | 26-Jan-23 | Grant | 17,375 | -- | -- | 68% 25.65K to 43.02K | |
| 30-Jan-23 4:15 PM View: | Silverstein Christine Berni Director | Marinus Pharmaceuticals, Inc. (MRNS) | 26-Jan-23 | Grant | 7,200 | -- | -- | 100% 0 to 7.2K | |
| 30-Jan-23 4:33 PM View: | Pfanstiel Steven Chief Financial Officer | Marinus Pharmaceuticals, Inc. (MRNS) | 26-Jan-23 | Grant | 28,130 | -- | -- | 117% 24.0K to 52.13K | |
| 30-Jan-23 4:38 PM View: | Hulihan Joseph Chief Medical Officer | Marinus Pharmaceuticals, Inc. (MRNS) | 26-Jan-23 | Grant | 25,648 | -- | -- | 103% 24.87K to 50.52K | |
| 30-Jan-23 4:26 PM View: | Ezickson Elan Director | Marinus Pharmaceuticals, Inc. (MRNS) | 26-Jan-23 | Grant | 3,600 | -- | -- | 131% 2.75K to 6.35K | |
| 30-Jan-23 4:24 PM View: | Fischer Seth H.Z. Director | Marinus Pharmaceuticals, Inc. (MRNS) | 26-Jan-23 | Grant | 3,600 | -- | -- | 105% 3.44K to 7.04K | |
| 30-Jan-23 4:18 PM View: | Austin Charles Director | Marinus Pharmaceuticals, Inc. (MRNS) | 26-Jan-23 | Grant | 3,600 | -- | -- | 131% 2.75K to 6.35K | |
| 30-Jan-23 4:21 PM View: | Nochur Sara Director | Marinus Pharmaceuticals, Inc. (MRNS) | 26-Jan-23 | Grant | 3,600 | -- | -- | 131% 2.75K to 6.35K | |
| 30-Jan-23 4:28 PM View: | Manning Martha E VP, GEN. COUNSEL & CORP. SEC. | Marinus Pharmaceuticals, Inc. (MRNS) | 26-Jan-23 | Grant | 16,548 | -- | -- | 89% 18.66K to 35.2K | |
| 14-Nov-22 7:43 AM View: | Shafer Christina Chief Commercial Officer | Marinus Pharmaceuticals, Inc. (MRNS) | 09-Nov-22 | Payment of Exercise | 1,505 | $4.70 | $7,073.50 | (6%) 27.15K to 25.65K | |
| 26-May-22 4:39 PM View: | Manning Martha E VP Gen Counsel and Corp Sec. | Marinus Pharmaceuticals, Inc. (MRNS) | 24-May-22 | Grant | 5,790 | -- | -- | 45% 12.87K to 18.66K | |
| 26-May-22 4:01 PM View: | Pfanstiel Steven Chief Financial Officer | Marinus Pharmaceuticals, Inc. (MRNS) | 24-May-22 | Grant | 7,448 | -- | -- | 45% 16.55K to 24.0K | |
| 26-May-22 4:02 PM View: | Hulihan Joseph Chief Medical Officer | Marinus Pharmaceuticals, Inc. (MRNS) | 24-May-22 | Grant | 7,718 | -- | -- | 45% 17.15K to 24.87K | |
| 26-May-22 4:01 PM View: | Braunstein Scott Chairman and CEO Director | Marinus Pharmaceuticals, Inc. (MRNS) | 24-May-22 | Grant | 19,305 | -- | -- | 28% 67.9K to 87.2K |
